Multivalent vaccine composition
The present invention relates to stable, immunogenic combination vaccine(s) comprising a mixture of antigens for prevention and prophylaxis of infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and Hepati...
Gespeichert in:
| Hauptverfasser: | , , , , , , , |
|---|---|
| Format: | Patent |
| Sprache: | chi ; eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | SABALE, RAJENDRA NARAYAN JIANG, BAOMING DHERE, RAJEEV MHALASAKANT KADAM, RAVINDRA BAPURAO ZADE, JAGDISH KAMALAJI PISAL, SAMBHAJI SHANKAR KAMBLE, ABHIJEET SANJEEV GLASS, ROGER |
| description | The present invention relates to stable, immunogenic combination vaccine(s) comprising a mixture of antigens for prevention and prophylaxis of infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and Hepatitis B virus. The invention particularly provides a multivalent combination vaccine comprising of (i) significantly dose reduced Salk IPV or Sabin IPV (IPV) antigens prepared by utilizing improved methods of formaldehyde inactivation and alum hydroxide adsorption resulting in maximum recovery of D-antigen and (ii) Injectable heat inactivated Rotavirus antigen(s) obtained from Rotavirus (CDC-9) strains that provides a broad cross-protective immunity among human rotavirus strains, (iii) Hib PRP -carrier protein conjugate having improved stability and immunogenicity wherein said Hib PRP -carrier protein conjugate is initially prepared by using novel conjugation process and subsequently blended at low temperature in pre |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_TW202038995A</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>TW202038995A</sourcerecordid><originalsourceid>FETCH-epo_espacenet_TW202038995A3</originalsourceid><addsrcrecordid>eNrjZJD3Lc0pySxLzEnNK1EoS0xOzsxLVUjOzy3IL84syczP42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8SHhRgZGBsYWlpamjsbEqAEAY7slqA</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>Multivalent vaccine composition</title><source>esp@cenet</source><creator>SABALE, RAJENDRA NARAYAN ; JIANG, BAOMING ; DHERE, RAJEEV MHALASAKANT ; KADAM, RAVINDRA BAPURAO ; ZADE, JAGDISH KAMALAJI ; PISAL, SAMBHAJI SHANKAR ; KAMBLE, ABHIJEET SANJEEV ; GLASS, ROGER</creator><creatorcontrib>SABALE, RAJENDRA NARAYAN ; JIANG, BAOMING ; DHERE, RAJEEV MHALASAKANT ; KADAM, RAVINDRA BAPURAO ; ZADE, JAGDISH KAMALAJI ; PISAL, SAMBHAJI SHANKAR ; KAMBLE, ABHIJEET SANJEEV ; GLASS, ROGER</creatorcontrib><description>The present invention relates to stable, immunogenic combination vaccine(s) comprising a mixture of antigens for prevention and prophylaxis of infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and Hepatitis B virus. The invention particularly provides a multivalent combination vaccine comprising of (i) significantly dose reduced Salk IPV or Sabin IPV (IPV) antigens prepared by utilizing improved methods of formaldehyde inactivation and alum hydroxide adsorption resulting in maximum recovery of D-antigen and (ii) Injectable heat inactivated Rotavirus antigen(s) obtained from Rotavirus (CDC-9) strains that provides a broad cross-protective immunity among human rotavirus strains, (iii) Hib PRP -carrier protein conjugate having improved stability and immunogenicity wherein said Hib PRP -carrier protein conjugate is initially prepared by using novel conjugation process and subsequently blended at low temperature in pre</description><language>chi ; eng</language><subject>BEER ; BIOCHEMISTRY ; CHEMISTRY ; COMPOSITIONS THEREOF ; CULTURE MEDIA ; ENZYMOLOGY ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; MICROBIOLOGY ; MICROORGANISMS OR ENZYMES ; MUTATION OR GENETIC ENGINEERING ; ORGANIC CHEMISTRY ; PEPTIDES ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS ; SPIRITS ; VINEGAR ; WINE</subject><creationdate>2020</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201101&DB=EPODOC&CC=TW&NR=202038995A$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76290</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20201101&DB=EPODOC&CC=TW&NR=202038995A$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>SABALE, RAJENDRA NARAYAN</creatorcontrib><creatorcontrib>JIANG, BAOMING</creatorcontrib><creatorcontrib>DHERE, RAJEEV MHALASAKANT</creatorcontrib><creatorcontrib>KADAM, RAVINDRA BAPURAO</creatorcontrib><creatorcontrib>ZADE, JAGDISH KAMALAJI</creatorcontrib><creatorcontrib>PISAL, SAMBHAJI SHANKAR</creatorcontrib><creatorcontrib>KAMBLE, ABHIJEET SANJEEV</creatorcontrib><creatorcontrib>GLASS, ROGER</creatorcontrib><title>Multivalent vaccine composition</title><description>The present invention relates to stable, immunogenic combination vaccine(s) comprising a mixture of antigens for prevention and prophylaxis of infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and Hepatitis B virus. The invention particularly provides a multivalent combination vaccine comprising of (i) significantly dose reduced Salk IPV or Sabin IPV (IPV) antigens prepared by utilizing improved methods of formaldehyde inactivation and alum hydroxide adsorption resulting in maximum recovery of D-antigen and (ii) Injectable heat inactivated Rotavirus antigen(s) obtained from Rotavirus (CDC-9) strains that provides a broad cross-protective immunity among human rotavirus strains, (iii) Hib PRP -carrier protein conjugate having improved stability and immunogenicity wherein said Hib PRP -carrier protein conjugate is initially prepared by using novel conjugation process and subsequently blended at low temperature in pre</description><subject>BEER</subject><subject>BIOCHEMISTRY</subject><subject>CHEMISTRY</subject><subject>COMPOSITIONS THEREOF</subject><subject>CULTURE MEDIA</subject><subject>ENZYMOLOGY</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>MICROBIOLOGY</subject><subject>MICROORGANISMS OR ENZYMES</subject><subject>MUTATION OR GENETIC ENGINEERING</subject><subject>ORGANIC CHEMISTRY</subject><subject>PEPTIDES</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</subject><subject>SPIRITS</subject><subject>VINEGAR</subject><subject>WINE</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2020</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZJD3Lc0pySxLzEnNK1EoS0xOzsxLVUjOzy3IL84syczP42FgTUvMKU7lhdLcDIpuriHOHrqpBfnxqcUFicmpeakl8SHhRgZGBsYWlpamjsbEqAEAY7slqA</recordid><startdate>20201101</startdate><enddate>20201101</enddate><creator>SABALE, RAJENDRA NARAYAN</creator><creator>JIANG, BAOMING</creator><creator>DHERE, RAJEEV MHALASAKANT</creator><creator>KADAM, RAVINDRA BAPURAO</creator><creator>ZADE, JAGDISH KAMALAJI</creator><creator>PISAL, SAMBHAJI SHANKAR</creator><creator>KAMBLE, ABHIJEET SANJEEV</creator><creator>GLASS, ROGER</creator><scope>EVB</scope></search><sort><creationdate>20201101</creationdate><title>Multivalent vaccine composition</title><author>SABALE, RAJENDRA NARAYAN ; JIANG, BAOMING ; DHERE, RAJEEV MHALASAKANT ; KADAM, RAVINDRA BAPURAO ; ZADE, JAGDISH KAMALAJI ; PISAL, SAMBHAJI SHANKAR ; KAMBLE, ABHIJEET SANJEEV ; GLASS, ROGER</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_TW202038995A3</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>chi ; eng</language><creationdate>2020</creationdate><topic>BEER</topic><topic>BIOCHEMISTRY</topic><topic>CHEMISTRY</topic><topic>COMPOSITIONS THEREOF</topic><topic>CULTURE MEDIA</topic><topic>ENZYMOLOGY</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>MICROBIOLOGY</topic><topic>MICROORGANISMS OR ENZYMES</topic><topic>MUTATION OR GENETIC ENGINEERING</topic><topic>ORGANIC CHEMISTRY</topic><topic>PEPTIDES</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS</topic><topic>SPIRITS</topic><topic>VINEGAR</topic><topic>WINE</topic><toplevel>online_resources</toplevel><creatorcontrib>SABALE, RAJENDRA NARAYAN</creatorcontrib><creatorcontrib>JIANG, BAOMING</creatorcontrib><creatorcontrib>DHERE, RAJEEV MHALASAKANT</creatorcontrib><creatorcontrib>KADAM, RAVINDRA BAPURAO</creatorcontrib><creatorcontrib>ZADE, JAGDISH KAMALAJI</creatorcontrib><creatorcontrib>PISAL, SAMBHAJI SHANKAR</creatorcontrib><creatorcontrib>KAMBLE, ABHIJEET SANJEEV</creatorcontrib><creatorcontrib>GLASS, ROGER</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>SABALE, RAJENDRA NARAYAN</au><au>JIANG, BAOMING</au><au>DHERE, RAJEEV MHALASAKANT</au><au>KADAM, RAVINDRA BAPURAO</au><au>ZADE, JAGDISH KAMALAJI</au><au>PISAL, SAMBHAJI SHANKAR</au><au>KAMBLE, ABHIJEET SANJEEV</au><au>GLASS, ROGER</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>Multivalent vaccine composition</title><date>2020-11-01</date><risdate>2020</risdate><abstract>The present invention relates to stable, immunogenic combination vaccine(s) comprising a mixture of antigens for prevention and prophylaxis of infections caused by Rotavirus, Poliomyelitis virus, Haemophilus influenzae, Corynebacterium diphtheriae, Clostridium tetani, Bordetella pertussis and Hepatitis B virus. The invention particularly provides a multivalent combination vaccine comprising of (i) significantly dose reduced Salk IPV or Sabin IPV (IPV) antigens prepared by utilizing improved methods of formaldehyde inactivation and alum hydroxide adsorption resulting in maximum recovery of D-antigen and (ii) Injectable heat inactivated Rotavirus antigen(s) obtained from Rotavirus (CDC-9) strains that provides a broad cross-protective immunity among human rotavirus strains, (iii) Hib PRP -carrier protein conjugate having improved stability and immunogenicity wherein said Hib PRP -carrier protein conjugate is initially prepared by using novel conjugation process and subsequently blended at low temperature in pre</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | chi ; eng |
| recordid | cdi_epo_espacenet_TW202038995A |
| source | esp@cenet |
| subjects | BEER BIOCHEMISTRY CHEMISTRY COMPOSITIONS THEREOF CULTURE MEDIA ENZYMOLOGY HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY MICROBIOLOGY MICROORGANISMS OR ENZYMES MUTATION OR GENETIC ENGINEERING ORGANIC CHEMISTRY PEPTIDES PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES PROPAGATING, PRESERVING OR MAINTAINING MICROORGANISMS SPIRITS VINEGAR WINE |
| title | Multivalent vaccine composition |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-31T08%3A39%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=SABALE,%20RAJENDRA%20NARAYAN&rft.date=2020-11-01&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3ETW202038995A%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |